Alzhaimer and treatment - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

Alzhaimer and treatment

Description:

Memory must be impaired to make the diagnosis of dementia. ... Jakob disease, HIV infection, progressive multifocal leucoencephalopathy) ... – PowerPoint PPT presentation

Number of Views:68
Avg rating:3.0/5.0
Slides: 21
Provided by: ALI1230
Category:

less

Transcript and Presenter's Notes

Title: Alzhaimer and treatment


1
(No Transcript)
2
Dementia
  • Progressive deterioration of intellect,
    behavior and personality as a consequence of
    diffuse disease of the brain hemispheres,
    maximally affecting the cerebral cortex and
    hippocampus.
  • Dementia is a symptom of disease rather
    than a single disease entity!!!

3
Dementia
4
  • Memory must be impaired to make the diagnosis of
    dementia.
  • Loss of memory for recent events is the earlist
    feature of dementia.
  • Subsequent symptoms include abnormal behavior,
    loss of intellect, mood changes, and difficulty
    coping with ordinary routes.
  • Insight may be retained initially, but is then
    usually lost.
  • Ultimately, there is loss of self-care,
    wandering, incontinence, and often paranoia.

5
  • Dementia may occur at any age but is more common
    in the elderly, accounting for 40 of long-term
    psychiatric in-patients over the age of 65 years.
  • The prevalence in persons aged between 50 and 70
    years is about 1 and in those approaching 90
    years reaches 50.
  • An annual incidence rate is 190/100 000 persons.

6
  • Clinical course
  • The rate of progression depends upon the
    underlying cause.
  • The duration of history helps establish the cause
    of dementia Alzheimers disease is slowly
    progressive over years, whereas encephalitis may
    be rapid over weeks. Dementia due to
    cerebrovascular disease appears to occur stroke
    by stroke.

7
Dementias classificationBased on cause
  • Alzheimers disease (60 of all dementias)
  • Cerebrovascular (multiinfarct state, subcortical
    small vessel, amyloid angiopathy,) (20)
  • Neurodegenerative (DLB, Picks disease,
    Huntingtons chorea, Parkinsons disease)
  • Infectious (Creutzfeld-Jakob disease, HIV
    infection, progressive multifocal
    leucoencephalopathy)
  • Normal pressure hydrocephalus
    TREATABLE!
  • Nutritional (thiamine deficiency in alcoholics!,
    B12 deficiency, folate deficiency)
  • Metabolic (hepatic disease, thyroid d.,
    parathyroid d., Cushings syndrome)
  • Chronic inflammatory (MS, )
  • Trauma (head injury, Punch drunk syndrome)
  • Tumour (e.g. subfrontal meningioma)

8
Alzhaimer and Treatment
9
Alzheimer's disease
  • The commonest cause of dementia.
  • The disorder rarely occurs under the age of 45
    years.
  • The incidence increases with age.
  • The cause of AD is not known (neurodegenerative
    d.).
  • Up to 30 of cases are familial (the loci were
    found on chromosome 21 and 19).
  • Pathology the presence of senile plaques and
    neurofibrillary tangles in the brain.
  • Diagnosis of AD may be established during life by
    early memory failure, slow progression and
    exclusion of other causes.

10
  • Age is the most powerful risk factor for the
    development of AD, 65-85 years doubling in every
    5 year age group (age 85 in the range of of
    30-40).

11
Risk factors
  • Gender (womengtmen)
  • Lower education
  • Family history
  • Coronary artery disease.
  • Hypertension
  • Hyperhemocysteine
  • Head trauma
  • Elevated fat in the diet

12
Reduce the risk of AD
  • The use of nonsteroidal anti- inflammatory drugs
    (NSAIDs)
  • Anti oxidants
  • Cholesterol lowering drugs

13
Alzheimer's disease
  • CT scanning aids diagnosis by excluding multiple
    infarction or a mass lesion.
  • MRI shows bilateral temporal lobe atrophy.
  • SPECT usually shows temporoparietal
    hypoperfusion.

14
Treatment
  • The primary pharmacological treatment AchE
    Inhibitors (AchEI)
  • Exelon (rivastigmine)
  • Reminyl (galantamine)
  • Aricept (donepezil)

15
  • Improvement in cognitive function.
    Neurobehavioral symptoms.
  • Apathy visual hallucinations.

16
  • Side effects
  • GI effects

17
  • Dose of medication is increased progressively
    until either beneficial effects are noted or side
    effects interfere.

18
  • Memantine (N-methyl-D-aspartate antagonist)
  • Awaiting a decision by the FDA (food drug
    Administration)
  • Blocking potential excitotoxic stimulation of CNS
    neurons.

19
Other medications
  • Vit E antioxidant 1000 IU (BD)
  • Estrogen or other hormone replacement
  • Neither low-Dose prednisolone or NSAIDs

20
Medications for Behavioral and neuropsychiatric
symptoms
  • Efficient lighting
  • Urinary tract infections
  • Depression (SSRIs) and anxiety and irritability
  • Agiotation (neuroleptic) risperidone-olonzapine
  • - (SSRI) citaloperam
  • Sleep (trazodone).
Write a Comment
User Comments (0)
About PowerShow.com